These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 7237446)
1. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma. Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446 [TBL] [Abstract][Full Text] [Related]
2. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma. Sava G; Giraldi T; Lassiani L; Nisi C Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062 [TBL] [Abstract][Full Text] [Related]
3. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential. Sava G; Giraldi T; Zupi G; Sacchi A Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289 [TBL] [Abstract][Full Text] [Related]
4. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma. Giraldi T; Sava G; Mitri E; Cherubino R Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195 [TBL] [Abstract][Full Text] [Related]
5. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice. Giraldi T; Houghton PJ; Taylor DM; Nisi C Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma. Sava G; Giraldi T; Nisi C; Bertoli G Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247 [TBL] [Abstract][Full Text] [Related]
7. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity. Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290 [TBL] [Abstract][Full Text] [Related]
8. Activity of 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt in M 5076/73A ovarian reticular cell sarcoma of the mouse. Colombo T; Garattini S; Lassiani L; D'Incalci M Cancer Treat Rep; 1982 Nov; 66(11):1945-8. PubMed ID: 6754075 [TBL] [Abstract][Full Text] [Related]
9. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt. Sava G; Zorzet S; Perissin L; Lassiani L; Tomasic J Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt. Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263 [TBL] [Abstract][Full Text] [Related]
11. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK. Sava G; Zorzet S; Perissin L; Pacor S; Lassiani L; Nisi C; Varnavas A Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076 [TBL] [Abstract][Full Text] [Related]
13. Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma. James SE; Salsbury AJ Cancer Res; 1974 Apr; 34(4):839-42. PubMed ID: 4814996 [No Abstract] [Full Text] [Related]
14. The effects of an antimetastatic agent, (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ICRF 159), on platelet behavior. Atherton A; Busfield D; Hellman K Cancer Res; 1975 Apr; 35(4):953-7. PubMed ID: 1116152 [TBL] [Abstract][Full Text] [Related]
15. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane. Salsbury AJ; Burrage K; Hellmann K Cancer Res; 1974 Apr; 34(4):843-9. PubMed ID: 4814997 [No Abstract] [Full Text] [Related]
16. Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK. Lassiani L; Ebert C; Nisi C; Varnavas A; Zorzet S; Sava G; Boccù E Pharmazie; 1990 Oct; 45(10):743-5. PubMed ID: 2089382 [TBL] [Abstract][Full Text] [Related]
17. Activity and inhibition by cytotoxic and antimetastatic drugs of cathepsin B-like cysteine proteinase in transplantable leukemias in mice. Giraldi T; Sava G; Zorzet S; Perissin L; Piccini P Anticancer Res; 1987; 7(3 Pt B):343-6. PubMed ID: 3307599 [TBL] [Abstract][Full Text] [Related]
18. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors. Wietrzyk J; Opolski A; Madej J; Radzikowski C Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell-surface neutral protease of Ehrlich ascites tumor cells by potassium p-(3,3-dimethyl-1-triazeno) benzoate. Steven FS; Brown BS; Hulley TP; Itzhaki S; Giraldi T; Lassiani L Biochem Int; 1985 Aug; 11(2):153-60. PubMed ID: 3902023 [TBL] [Abstract][Full Text] [Related]
20. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation. Wietrzyk J; Opolski A; Madej J; Radzikowski C In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]